PL2214021T3 - Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym - Google Patents
Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganymInfo
- Publication number
- PL2214021T3 PL2214021T3 PL10162987T PL10162987T PL2214021T3 PL 2214021 T3 PL2214021 T3 PL 2214021T3 PL 10162987 T PL10162987 T PL 10162987T PL 10162987 T PL10162987 T PL 10162987T PL 2214021 T3 PL2214021 T3 PL 2214021T3
- Authority
- PL
- Poland
- Prior art keywords
- kit
- csf
- implantation success
- assisted fertilisation
- predicting
- Prior art date
Links
- 238000002513 implantation Methods 0.000 title abstract 2
- 210000001733 follicular fluid Anatomy 0.000 abstract 5
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 abstract 4
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 abstract 4
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 210000000287 oocyte Anatomy 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 210000002257 embryonic structure Anatomy 0.000 abstract 1
- 230000004720 fertilization Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83209406P | 2006-07-21 | 2006-07-21 | |
EP07787688A EP2049906B1 (en) | 2006-07-21 | 2007-07-18 | Assay and kit for predicting implantation success in assisted fertilisation |
EP10162987.1A EP2214021B1 (en) | 2006-07-21 | 2007-07-18 | Kit for predicting implantation success in assisted fertilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2214021T3 true PL2214021T3 (pl) | 2015-06-30 |
Family
ID=38529962
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10162987T PL2214021T3 (pl) | 2006-07-21 | 2007-07-18 | Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym |
PL07787688T PL2049906T3 (pl) | 2006-07-21 | 2007-07-18 | Test i zestaw do przewidywania powodzenia zagnieżdżenia zarodka we wspomaganym zapłodnieniu |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07787688T PL2049906T3 (pl) | 2006-07-21 | 2007-07-18 | Test i zestaw do przewidywania powodzenia zagnieżdżenia zarodka we wspomaganym zapłodnieniu |
Country Status (21)
Country | Link |
---|---|
US (1) | US8211650B2 (pl) |
EP (5) | EP2857840B8 (pl) |
JP (1) | JP5052609B2 (pl) |
KR (2) | KR101482568B1 (pl) |
CN (2) | CN106199004B (pl) |
AT (1) | ATE468538T1 (pl) |
AU (1) | AU2007275112B2 (pl) |
BR (1) | BRPI0714494B1 (pl) |
CA (1) | CA2658665C (pl) |
DE (1) | DE602007006672D1 (pl) |
DK (2) | DK2214021T3 (pl) |
EA (1) | EA016348B1 (pl) |
ES (4) | ES2345571T3 (pl) |
HK (2) | HK1128760A1 (pl) |
HR (2) | HRP20100382T8 (pl) |
MX (1) | MX2009000569A (pl) |
MY (1) | MY150687A (pl) |
NZ (1) | NZ574135A (pl) |
PL (2) | PL2214021T3 (pl) |
PT (2) | PT2049906E (pl) |
WO (1) | WO2008009705A1 (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8338373B2 (en) | 2003-10-24 | 2012-12-25 | Nora Therapeutics, Inc. | Method for reducing the risk of spontaneous abortion in a human female subject |
EP2140875A1 (en) | 2003-10-24 | 2010-01-06 | Nora, LLC | Compositions and methods for healthy pregnancy |
US20090226397A1 (en) | 2003-10-24 | 2009-09-10 | Nora Therapeutics, Inc. | Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination |
US9176145B2 (en) | 2006-07-21 | 2015-11-03 | Femalon S.P.R.L. | Kit for predicting implantation success in assisted fertilization |
GB0806281D0 (en) * | 2008-04-07 | 2008-05-14 | Univ Leeds | Markers of Oocyte viability |
JP5902478B2 (ja) * | 2008-05-01 | 2016-04-13 | ザイモジェネティクス, インコーポレイテッド | 血清中のBLyS/APRILヘテロ三量体レベルおよび診断方法における使用 |
WO2010126528A1 (en) * | 2009-05-01 | 2010-11-04 | Nora Therapeutics, Inc. | Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination |
WO2010151221A1 (en) * | 2009-06-25 | 2010-12-29 | Phase Holographic Imaging Phi Ab | Analysis of ova or embryos with digital holographic imaging |
WO2011000805A1 (en) | 2009-06-29 | 2011-01-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarkers of oocyte competency and method of use |
US9753042B2 (en) * | 2013-04-23 | 2017-09-05 | Rosalind Franklin University Of Medicine And Science | Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures |
EP3126836A4 (en) * | 2014-04-02 | 2017-11-08 | Prince Henry's Insitute of Medical Research Trading as The Hudson Institute of Medical Research | A prognostic assay for succes of assisted reproductive technology |
CN104450904A (zh) * | 2014-12-02 | 2015-03-25 | 柳州市妇幼保健院 | 利用颗粒细胞端粒长度来判断胚胎发育潜能的方法 |
AU2016330398B2 (en) * | 2015-09-30 | 2022-11-10 | Hudson Institute of Medical Research | A method of treatment and prognosis |
CN110361534B (zh) * | 2018-03-26 | 2023-11-03 | 山大生殖研发中心有限公司 | 评估胚胎和预测体外受精成功率的化学标记物和其应用 |
RU2746644C1 (ru) * | 2021-01-21 | 2021-04-19 | Мекан Рахимбердыевич Оразов | Способ оценки имплантационной состоятельности эндометрия при повторных неудачах имплантации, ассоциированных с хроническим эндометритом |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
ATE167301T1 (de) | 1988-03-24 | 1998-06-15 | Terrapin Tech Inc | Gruppe von getrennten peptiden |
JP3058673B2 (ja) * | 1989-11-10 | 2000-07-04 | 株式会社明電舎 | サイトカインの測定方法及びその測定用キット |
GB9603326D0 (en) | 1996-02-16 | 1996-04-17 | Royal Free Hosp School Med | Predictive assay |
JP5271481B2 (ja) * | 1999-09-08 | 2013-08-21 | 中外製薬株式会社 | タンパク質溶液製剤およびその安定化方法 |
US6555660B2 (en) * | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
JP4444652B2 (ja) | 2001-07-11 | 2010-03-31 | マキシゲン・ホールディングズ・リミテッド | G−csf結合体 |
-
2007
- 2007-07-08 MY MYPI20090249 patent/MY150687A/en unknown
- 2007-07-18 EP EP15150111.1A patent/EP2857840B8/en not_active Not-in-force
- 2007-07-18 DK DK10162987.1T patent/DK2214021T3/en active
- 2007-07-18 PT PT07787688T patent/PT2049906E/pt unknown
- 2007-07-18 PT PT10162987T patent/PT2214021E/pt unknown
- 2007-07-18 DE DE602007006672T patent/DE602007006672D1/de active Active
- 2007-07-18 EP EP10162987.1A patent/EP2214021B1/en active Active
- 2007-07-18 PL PL10162987T patent/PL2214021T3/pl unknown
- 2007-07-18 CA CA2658665A patent/CA2658665C/en not_active Expired - Fee Related
- 2007-07-18 EP EP19194901.5A patent/EP3627156A1/en not_active Withdrawn
- 2007-07-18 JP JP2009519979A patent/JP5052609B2/ja not_active Expired - Fee Related
- 2007-07-18 EP EP17175527.5A patent/EP3267198B1/en active Active
- 2007-07-18 KR KR20097003510A patent/KR101482568B1/ko active IP Right Grant
- 2007-07-18 CN CN201610595863.7A patent/CN106199004B/zh not_active Expired - Fee Related
- 2007-07-18 EP EP07787688A patent/EP2049906B1/en active Active
- 2007-07-18 ES ES07787688T patent/ES2345571T3/es active Active
- 2007-07-18 PL PL07787688T patent/PL2049906T3/pl unknown
- 2007-07-18 KR KR1020147006802A patent/KR20140040289A/ko not_active Application Discontinuation
- 2007-07-18 AT AT07787688T patent/ATE468538T1/de active
- 2007-07-18 BR BRPI0714494A patent/BRPI0714494B1/pt not_active IP Right Cessation
- 2007-07-18 US US12/374,472 patent/US8211650B2/en not_active Expired - Fee Related
- 2007-07-18 ES ES10162987.1T patent/ES2531853T3/es active Active
- 2007-07-18 WO PCT/EP2007/057430 patent/WO2008009705A1/en active Application Filing
- 2007-07-18 AU AU2007275112A patent/AU2007275112B2/en not_active Ceased
- 2007-07-18 ES ES17175527T patent/ES2754707T3/es active Active
- 2007-07-18 CN CNA2007800276378A patent/CN101495871A/zh active Pending
- 2007-07-18 EA EA200900210A patent/EA016348B1/ru unknown
- 2007-07-18 ES ES15150111.1T patent/ES2634527T3/es active Active
- 2007-07-18 NZ NZ574135A patent/NZ574135A/en not_active IP Right Cessation
- 2007-07-18 MX MX2009000569A patent/MX2009000569A/es active IP Right Grant
- 2007-07-18 DK DK07787688.6T patent/DK2049906T3/da active
-
2009
- 2009-05-19 HK HK09104568.5A patent/HK1128760A1/xx not_active IP Right Cessation
-
2010
- 2010-07-09 HR HR20100382T patent/HRP20100382T8/xx unknown
-
2015
- 2015-03-05 HR HRP20150251TT patent/HRP20150251T1/hr unknown
- 2015-09-18 HK HK15109190.2A patent/HK1208529A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20150251T1 (en) | Kit for predicting implantation success in assisted fertilisation | |
EA201101141A1 (ru) | Получение закрытой линейной днк | |
NZ598293A (en) | Imaging and evaluating embryos, oocytes, and stem cells | |
BR112015022821A2 (pt) | método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico | |
TW200730138A (en) | Image analysis methods for gleno-humeral joint morphology | |
MX2021015876A (es) | Analisis del transcriptoma de plasma materno mediante secuenciacion de arn en paralelo a gran escala. | |
DE602007012766D1 (de) | Verfahren zur quantitativen cDNA-Analyse in Einzelzellen | |
EP2657697A3 (en) | Methods for determining the risk of chromosomal abnormality in a fetus | |
WO2009125219A3 (en) | Markers of oocyte viability | |
BR112012025022A2 (pt) | "método de redução da fragmentação de dna em uma amostra de espermatozoides separados" | |
MX2014015000A (es) | Metodos para aumentar el progreso genetico en una linea o raza de cerdo con celulas de esperma seleccionadas por sexo. | |
Tessaro et al. | Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte fertilization test | |
MX2012005388A (es) | Reactivos y metodos para detectar globulos blancos pnh tipo ii y su identificacion como factores de riesgo para transtornos trombolicos. | |
WO2009059289A3 (en) | Netrin-1 compositions and methods of use thereof | |
WO2010045323A3 (en) | A novel sorting technology that allows for highly efficient selection of sperm without chromatin damage | |
RU2012149631A (ru) | СПОСОБ ПОЛУЧЕНИЯ aRNA И СПОСОБ АНАЛИЗА ЭКСПРЕССИИ ГЕНА | |
BR112017007213A2 (pt) | "processamento e utilização de fluidos do trato reprodutivo para melhorar a produção in vitro de embriões de mamífero" | |
Sepulveda et al. | Comparison of a single medium with sequential media for culture of sibling human embryos to the blastocyst stage | |
RU2013135071A (ru) | Способ определения адгезивности клеток крови | |
Todorova et al. | Gene Panel in Human Cumulus Cells as Biomarker for Successful in vitro Procedures | |
PL399243A1 (pl) | Sposób dostarczania próbki plynu ustrojowego do ukladu analizujacego | |
UA39101U (ru) | Способ прогнозирования эффективности осеменения свиноматок замороженной-оттаявшей спермой | |
TEIXEIRA et al. | Luteal volume and progesterone serum concentration in Santa Ines sheep sinchronize with GnRH in a long or a short protocols. | |
UA50356U (ru) | Способ определения качества лабораторных культур паразитических перепончатокрылых энтомофагов | |
Eyries et al. | Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension |